Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.670
+0.050 (3.09%)
At close: Dec 5, 2025, 4:00 PM EST
1.650
-0.020 (-1.20%)
After-hours: Dec 5, 2025, 7:06 PM EST

Ovid Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
11966228131219147
Upgrade
Market Cap Growth
62.69%-70.87%73.64%-40.03%49.16%-26.16%
Upgrade
Enterprise Value
1071915791760
Upgrade
Last Close Price
1.670.933.221.863.212.31
Upgrade
PE Ratio
----1.82-
Upgrade
PS Ratio
17.96117.14580.5987.221.0511.61
Upgrade
PB Ratio
2.660.972.590.991.223.36
Upgrade
P/TBV Ratio
2.660.972.600.991.223.38
Upgrade
P/FCF Ratio
----1.85-
Upgrade
P/OCF Ratio
----1.84-
Upgrade
EV/Sales Ratio
16.2032.98400.056.300.084.73
Upgrade
EV/EBITDA Ratio
----0.14-
Upgrade
EV/EBIT Ratio
----0.14-
Upgrade
EV/FCF Ratio
----0.14-
Upgrade
Debt / Equity Ratio
0.310.220.180.13--
Upgrade
Asset Turnover
0.080.010.000.011.540.16
Upgrade
Quick Ratio
3.775.049.2318.4512.693.27
Upgrade
Current Ratio
4.245.329.5518.7912.873.39
Upgrade
Return on Equity (ROE)
-60.06%-33.88%-47.57%-34.72%109.98%-142.60%
Upgrade
Return on Assets (ROA)
-29.33%-30.90%-24.05%-19.85%57.40%-64.93%
Upgrade
Return on Capital (ROIC)
-32.59%-39.07%-28.49%-21.13%69.51%-89.56%
Upgrade
Return on Capital Employed (ROCE)
-68.50%-71.50%-43.40%-37.50%69.10%-151.20%
Upgrade
Earnings Yield
-30.16%-39.87%-23.00%-41.33%56.20%-55.30%
Upgrade
FCF Yield
-31.92%-84.50%-20.13%-43.07%54.18%-35.29%
Upgrade
Buyback Yield / Dilution
-0.35%-0.46%-0.22%-3.46%-16.45%-49.05%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.